Abpro Holdings Inc. (ABPO) vs Iterum Therapeutics PLC (ITRMF)

Abpro Holdings Inc. and Iterum Therapeutics PLC are both Biotechnology companies. Iterum Therapeutics PLC is the larger, with a market value of $1.6M against $1.4M — 1.1× the size. Iterum Therapeutics PLC has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.2×. Abpro Holdings Inc. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 12 metrics below, Abpro Holdings Inc. leads on 8 and Iterum Therapeutics PLC on 4.

Valuation

Metric ABPO ITRMF Biotechnology median
P/E 0.20 n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.41 n/m 0.74
EV/Sales n/m 24.37 10.73
Earnings yield 500.00% 0.00% (28.84%)
Free cash flow yield (311.42%) 0.00% (23.03%)

Profitability

Metric ABPO ITRMF Biotechnology median
Gross margin — (81.85%) 65.16%
Operating margin 0.00% (2,243.48%) 0.00%
Net margin 0.00% (2,930.54%) 0.00%
Free cash flow margin 0.00% (2,122.61%) 0.00%
Return on equity (20.18%) 285.48% (57.72%)
Return on assets 46.10% (111.35%) (49.22%)
Return on invested capital 0.00% (455.51%) 0.00%

Growth

Metric ABPO ITRMF Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 94.15% 57.43% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO ITRMF Biotechnology median
Debt to equity 0.00 (2.87) 0.00
Current ratio 0.62 2.13 4.73
Net debt to EBITDA 0.01 0.24 0.96

Dividend

Metric ABPO ITRMF Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABPO ITRMF Biotechnology median
Market cap 1.42m 1.59m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack